patient advocacy

News

Alarm bell rung over EU’s unified HTA plan

The EU’s joint clinical assessment (JCA) initiative has been set up to accelerate patient access to new therapies, but could end up restricting the use of new technologies

Patients
Live from Reuters Pharma USA 2023

Reuters Pharma USA – Kevin Hagan

Working in the pharma industry, it’s important to be aware of the impact of policies on all stakeholders, from industry colleagues, to payers and providers, and to patients – including low-

Events
Copy of PharmaPhorum
Partner Content

2nd Annual Gene Therapy Patient Engagement Summit

As investment in gene therapies continues to grow rapidly, more effectively engaging patients throughout development has become a priority for any company serious about building safer and more mean